Distinct Functions of Neutrophil in Cancer and Its Regulation

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Granot, Zvi ^a   Jablonska, Jadwiga ^b  

^a HEBREW UNIVERSITY   (Israel)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHEMOATTRACTANT; CYTOKINE; GROWTH FACTOR; INTERFERON; ONCOSTATIN M; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER PATIENT; CANCER PROGNOSIS; CARCINOGENESIS; CELL FUNCTION; CELL MIGRATION; CELL POLARITY; CELL SURFACE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; EXTRACELLULAR MATRIX; EXTRACELLULAR TRAP; HUMAN; IMMUNOCOMPETENT CELL; LEUKOCYTE ACTIVATION; METASTASIS; NEOPLASM; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL NICHE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANGIOGENESIS; ANIMAL; CELL MOTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; TUMOR ESCAPE;

ANIMALS; CELL MOVEMENT; CELL POLARITY; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; HUMANS; INTERFERONS; LYMPHOCYTE ACTIVATION; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; NEUTROPHILS; TUMOR ESCAPE; TUMOR MICROENVIRONMENT;

EID: 84948844143     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/701067     Document Type: Review

References (134)

1. Y. Nakamoto, L. G. Guidotti, C. V. Kuhlen, P. Fowler, and F. V. Chisari, "Immune pathogenesis of hepatocellular carcinoma, " Journal of Experimental Medicine, vol. 188, no. 2, pp. 341-350, 1998.
2. G. Rogler, "Chronic ulcerative colitis and colorectal cancer, " Cancer Letters, vol. 345, no. 2, pp. 235-241, 2014.
3. K. Shang, Y.-P. Bai, C. Wang et al., "Crucial involvement of tumor-Associated neutrophils in the regulation of chronic colitis-Associated carcinogenesis in mice, " PLoS ONE, vol. 7, no. 12, Article ID e51848, 2012.
4. M. van Egmond and J. E. Bakema, "Neutrophils as effector cells for antibody-based immunotherapy of cancer, " Seminars in Cancer Biology, vol. 23, no. 3, pp. 190-199, 2013.
5. Z. Granot, E. Henke, E. A. Comen, T. A. King, L. Norton, and R. Benezra, "Tumor entrained neutrophils inhibit seeding in the premetastatic lung, " Cancer Cell, vol. 20, no. 3, pp. 300-314, 2011.
6. M. Kowanetz, X. Wu, J. Lee et al., "Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 50, pp. 21248-21255, 2010.
7. M. A. Lpez-Lago, S. Posner, V. J. Thodima, A.M. Molina, R. J. Motzer, and R. S. K. Chaganti, "Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression, " Oncogene, vol. 32, no. 14, pp. 1752-1760, 2013.
8. J. Y. Sagiv, J. Michaeli, S. Assi et al., "Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer, " Cell Reports, vol. 10, no. 4, pp. 562-573, 2015.
9. R. V. Sionov, Z. G. Fridlender, and Z. Granot, "Themultifaceted roles neutrophils play in the tumor microenvironment, " Cancer Microenvironment, pp. 1-34, 2014.
10. D. V. Kalvakolanu, "Interferons and cell growth control, " Histology and Histopathology, vol. 15, no. 2, pp. 523-537, 2000.
11. M. M. Brierley and E. N. Fish, "Review: IFN-receptor interactions to biologic outcomes: understanding the circuitry, " Journal of Interferon and Cytokine Research, vol. 22, no. 8, pp. 835-845, 2002.
12. J. Jablonska, S. Leschner, K. Westphal, S. Lienenklaus, and S. Weiss, "Neutrophils responsive to endogenous IFN-regulate tumor angiogenesis and growth in a mouse tumor model, " Journal of Clinical Investigation, vol. 120, no. 4, pp. 1151-1164, 2010.
13. L. Andzinski, C.-F. Wu, S. Lienenklaus, A. Krger, S. Weiss, and J. Jablonska, "Delayed apoptosis of tumor associated neutrophils in the absence of endogenous IFN, " International Journal of Cancer, vol. 136, no. 3, pp. 572-583, 2015.
14. J. Jablonska, C.-F. Wu, L. Andzinski, S. Leschner, and S. Weiss, "CXCR2-mediated tumor-Associated neutrophil recruitment is regulated by IFN-beta, " International Journal of Cancer, vol. 134, no. 6, pp. 1346-1358, 2014.
15. C.-F. Wu, L. Andzinski, N. Kasnitz et al., "The lack of type I interferon induces neutrophil-mediated pre-metastatic niche formation in the mouse lung, " International Journal of Cancer, vol. 137, no. 4, pp. 837-847, 2015.
16. Z. G. Fridlender, J. Sun, S. Kim et al., "Polarization of tumorassociated neutrophil phenotype by TGF-: N1 versus N2 TAN, " Cancer Cell, vol. 16, no. 3, pp. 183-194, 2009.
17. S. V. Novitskiy, M. W. Pickup, A. Chytil, D. Polosukhina, P. Owens, and H. L. Moses, "Deletion of TGF-signaling in myeloid cells enhances their anti-Tumorigenic properties, " Journal of Leukocyte Biology, vol. 92, no. 3, pp. 641-651, 2012.
18. J. Bubeni, P. Perlmann, K. Helmstein, and G. Moberger, "Cellular and humoral immune responses to human urinary bladder carcinomas, " International Journal of Cancer, vol. 5, no. 3, pp. 310-319, 1970.
19. J. Dissemond, T. K. Weimann, L. A. Schneider et al., "Activated neutrophils exert antitumor activity against human melanoma cells: reactive oxygen species-induced mechanisms and their modulation by granulocyte-macrophage-colonystimulating factor, " Journal of InvestigativeDermatology, vol. 121, no. 4, pp. 936-938, 2003.
20. M. Zivkovic, M. Poljak-Blazi, G. Egger, S. B. Sunjic, R. J. Schaur, and N. Zarkovic, "Oxidative burst and anticancer activities of rat neutrophils, " BioFactors, vol. 24, no. 1-4, pp. 305-312, 2005.
21. R. A. Clark and S. J. Klebanoff, "Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system, " Journal of Experimental Medicine, vol. 141, no. 6, pp. 1442-1447, 1975.
22. B. H. Kushner and N.-K. V. Cheung, "Absolute requirement of CD11/CD18 adhesion molecules, FcRII and the phosphatidylinositol-linked FcRIII for monoclonal antibody-mediated neutrophil antihuman tumor cytotoxicity, " Blood, vol. 79, no. 6, pp. 1484-1490, 1992.
23. D. Iliopoulos, C. Ernst, Z. Steplewski et al., "Inhibition ofmetastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides, " Journal of the National Cancer Institute, vol. 81, no. 6, pp. 440-444, 1989.
24. T. Valerius, R. Repp, T. P. M. de Wit et al., "Involvement of the high-Affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy, " Blood, vol. 82, no. 3, pp. 931-939, 1993.
25. F. J. Hernandez-Ilizaliturri, V. Jupudy, J. Ostberg et al., "Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkins lymphoma severe combined immunodeficiencymousemodel, " Clinical Cancer Research, vol. 9, no. 16, part 1, pp. 5866-5873, 2003.
26. P. Hubert, A. Heitzmann, S. Viel et al., "Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy, " Cancer Research, vol. 71, no. 15, pp. 5134-5143, 2011.
27. Y. Guettinger, K. Barbin, M. Peipp et al., "A recombinant bispecific single-chain fragment variable specific for HLA class II and FcRI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cells, " Journal of Immunology, vol. 184, no. 3, pp. 1210-1217, 2010.
28. F. Fioretti, D. Fradelizi, A. Stoppacciaro et al., "Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor, " Journal of Immunology, vol. 161, no. 1, pp. 342-346, 1998.
29. A. Stoppacciaro, C. Melani, M. Parenza et al., "Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon, " Journal of Experimental Medicine, vol. 178, no. 1, pp. 151-161, 1993.
30. F. Cavallo, M. Giovarelli, A. Gulino et al., "Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene, " The Journal of Immunology, vol. 149, no. 11, pp. 3627-3635, 1992.
31. E. B. Eruslanov, P. S. Bhojnagarwala, J. G. Quatromoni et al., "Tumor-Associated neutrophils stimulate T cell responses in early-stage human lung cancer, " Journal of Clinical Investigation, vol. 124, no. 12, pp. 5466-5480, 2014.
32. K. Tillack, P. Breiden, R. Martin, and M. Sospedra, "T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses, " Journal of Immunology, vol. 188, no. 7, pp. 3150-3159, 2012.
33. S. Berger-Achituv, V. Brinkmann, U. A. Abed et al., "A proposed role for neutrophil extracellular traps in cancer immunoediting, " Frontiers in Immunology, vol. 4, article 48, 2013.
34. C. Beauvillain, Y. Delneste, M. Scotet et al., "Neutrophils efficiently cross-prime naive T cells in vivo, " Blood, vol. 110, no. 8, pp. 2965-2973, 2007.
35. G. F. Whalen, "Solid tumours and wounds: Transformed cells misunderstood as injured tissue?"TheLancet, vol. 336, no. 8729, pp. 1489-1492, 1990.
36. N. Antonio, M. L. Bonnelykke-Behrndtz, L. C. Ward et al., "The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer, " The EMBO Journal, vol. 34, no. 17, pp. 2219-2236, 2015.
37. C. Tecchio, P. Scapini, G. Pizzolo, and M.A. Cassatella, "On the cytokines produced by human neutrophils in tumors, " Seminars in Cancer Biology, vol. 23, no. 3, pp. 159-170, 2013.
38. M. A. Cassatella, "Neutrophil-derived proteins: selling cytokines by the pound, " Advances in Immunology, vol. 73, pp. 369-509, 1999.
39. G. R. Grotendorst, G. Smale, and D. Pencev, "Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils, " Journal of Cellular Physiology, vol. 140, no. 2, pp. 396-402, 1989.
40. M. McCourt, J. H. Wang, S. Sookhai, and H. P. Redmond, "Activated human neutrophils release hepatocyte growth factor/scatter factor, " European Journal of Surgical Oncology, vol. 27, no. 4, pp. 396-403, 2001.
41. M. M. Queen, R. E. Ryan, R.G. Holzer, C. R. Keller-Peck, and C. L. Jorcyk, "Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression, " Cancer Research, vol. 65, no. 19, pp. 8896-8904, 2005.
42. N. Normanno, A. De Luca, C. Bianco et al., "Epidermal growth factor receptor (EGFR) signaling in cancer, " Gene, vol. 366, no. 1, pp. 2-16, 2006.
43. C. L. Arteaga, "Epidermal growth factor receptor dependence in human tumors: more than just expression?" Oncologist, vol. 7, supplement 4, pp. 31-39, 2002.
44. D. S. Salomon, R. Brandt, F. Ciardiello, and N. Normanno, "Epidermal growth factor-related peptides and their receptors in human malignancies, " Critical Reviews in Oncology and Hematology, vol. 19, no. 3, pp. 183-232, 1995.
45. S. Wojtowicz-Praga, "Reversal of tumor-induced immunosuppression by TGF-inhibitors, " Investigational New Drugs, vol. 21, no. 1, pp. 21-32, 2003.
46. B. Bierie and H. L. Moses, "Transforming growth factor beta (TGF-and inflammation in cancer, " Cytokine and Growth Factor Reviews, vol. 21, no. 1, pp. 49-59, 2010.
47. M. H. Barcellos-Hoff and T.A. Dix, "Redox-mediated activation of latent transforming growth factor-1, "Molecular Endocrinology, vol. 10, no. 9, pp. 1077-1083, 1996.
48. T. Parekh, B. Saxena, J. Reibman, B.N. Cronstein, and L. I. Gold, "Neutrophil chemotaxis in response to TGF-beta isoforms (TGF-beta 1, TGF-beta 2, TGF-beta 3) is mediated by fibronectin, " The Journal of Immunology, vol. 152, no. 5, pp. 2456-2466, 1994.
49. J. Reibman, S. Meixler, T. C. Lee et al., "Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-Transduction pathways, " Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 15, pp. 6805-6809, 1991.
50. T. F. Deuel, R. M. Senior, J. S. Huang, and G. L. Griffin, "Chemotaxis of monocytes and neutrophils to platelet-derived growth factor, " The Journal of Clinical Investigation, vol. 69, no. 4, pp. 1046-1049, 1982.
51. L. Uhrbom, G. Hesselager, M. Nistr, and B. Westermark, "Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus, " Cancer Research, vol. 58, no. 23, pp. 5275-5279, 1998.
52. G. McMahon, "VEGF receptor signaling in tumor angiogenesis, " Oncologist, vol. 5, supplement 1, pp. 3-10, 2000.
53. D. R. Senger, "Vascular endothelial growth factor: much more than an angiogenesis factor, " Molecular Biology of the Cell, vol. 21, no. 3, pp. 377-379, 2010.
54. H. L. Goel and A.M. Mercurio, "VEGF targets the tumour cell, " Nature Reviews Cancer, vol. 13, no. 12, pp. 871-882, 2013.
55. R. C. Bates, J. D. Goldsmith, R. E. Bachelder et al., "Flt-1-dependent survival characterizes the epithelial-mesenchymal transition of colonic organoids, " Current Biology, vol. 13, no. 19, pp. 1721-1727, 2003.
56. R. E. Bachelder, A. Crago, J. Chung et al., "Vascular endothelial growth factor is an autocrine survival factor for neuropilinexpressing breast carcinoma cells, " Cancer Research, vol. 61, no. 15, pp. 5736-5740, 2001.
57. M. J. Barr, D. J. Bouchier-Hayes, and J. H. Harmey, "Vascular endothelial growth factor is an autocrine survival factor for breast tumour cells under hypoxia, " International Journal of Oncology, vol. 32, no. 1, pp. 41-48, 2008.
58. A. Grenier, M. Dehoux, A. Boutten et al., "Oncostatin M production and regulation by human polymorphonuclear neutrophils, " Blood, vol. 93, no. 4, pp. 1413-1421, 1999.
59. S. M. Kerfoot, E. Raharjo, M. Ho et al., "Exclusive neutrophil recruitment with oncostatin M in a human system, " The American Journal of Pathology, vol. 159, no. 4, pp. 1531-1539, 2001.
60. J. M. Zarling, M. Shoyab, H. Marquardt, M. B. Hanson, M. N. Lioubin, and G. J. Todaro, "Oncostatin M: A growth regulator produced by differentiated histiocytic lymphoma cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 24, pp. 9739-9743, 1986.
61. J. Liu, N. Hadjokas, B. Mosley, Z. Estrov, M. J. Spence, and R. E. Vestal, "Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells, " Cytokine, vol. 10, no. 4, pp. 295-302, 1998.
62. R. G. Holzer, R. E. Ryan, M. Tommack, E. Schlekeway, and C. L. Jorcyk, "OncostatinMstimulates the detachment of a reservoir of invasive mammary carcinoma cells: role of cyclooxygenase-2, " Clinical and Experimental Metastasis, vol. 21, no. 2, pp. 167-176, 2004.
63. R. J. Moore, D. M. Owens, G. Stamp et al., "Mice deficient in tumor necrosis factor-are resistant to skin carcinogenesis, " Nature Medicine, vol. 5, no. 7, pp. 828-831, 1999.
64. F.-M. Gu, Q.-L. Li, Q. Gao et al., "IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma, " Molecular Cancer, vol. 10, article 150, 2011.
65. J.-L. Luo, S. Maeda, L.-C. Hsu, H. Yagita, and M. Karin, "Inhibition of NF-B in cancer cells converts inflammation-induced tumor growth mediated by TNF to TRAIL-mediated tumor regression, " Cancer Cell, vol. 6, no. 3, pp. 297-305, 2004.
66. R. C. A. Sainson, D. A. Johnston, H. C. Chu et al., "TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype, " Blood, vol. 111, no. 10, pp. 4997-5007, 2008.
67. Y. Jing, N. Ma, T. Fan et al., "Tumor necrosis factor-Alpha promotes tumor growth by inducing vascular endothelial growth factor, " Cancer Investigation, vol. 29, no. 7, pp. 485-493, 2011.
68. H.-E. Tzeng, C.-H. Tsai, Z.-L. Chang et al., "Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma, " Biochemical Pharmacology, vol. 85, no. 4, pp. 531-540, 2013.
69. H. Nozawa, C. Chiu, and D. Hanahan, "Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis, " Proceedings of theNational Academy of Sciences of the United States of America, vol. 103, no. 33, pp. 12493-12498, 2006.
70. R. Benelli, M. Morini, F. Carrozzino et al., "Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation, " The FASEB Journal, vol. 16, no. 2, pp. 267-269, 2002.
71. J. P. Shaw, N. Chuang, H. Yee, and P. Shamamian, "Polymorphonuclear neutrophils promote rFGF-2-induced angiogenesis in vivo, " Journal of Surgical Research, vol. 109, no. 1, pp. 37-42, 2003.
72. T. Mentzel, L. F. Brown, H. F. Dvorak et al., "The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma, " Virchows Archiv, vol. 438, no. 1, pp. 13-22, 2001.
73. P. E. Van Den Steen, B. Dubois, I. Nelissen, P. M. Rudd, R. A. Dwek, and G. Opdenakker, "Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9), " Critical Reviews in Biochemistry and Molecular Biology, vol. 37, no. 6, pp. 375-536, 2002.
74. L. M. Coussens, C. L. Tinkle, D. Hanahan, and Z. Werb, "MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis, " Cell, vol. 103, no. 3, pp. 481-490, 2000.
75. G. Bergers, R. Brekken, G. McMahon et al., "Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis, " Nature Cell Biology, vol. 2, no. 10, pp. 737-744, 2000.
76. P. E. Van den Steen, P. Proost, A. Wuyts, J. VanDamme, and G. Opdenakker, "Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-and leaves RANTES and MCP-2 intact, " Blood, vol. 96, no. 8, pp. 2673-2681, 2000.
77. B. Heissig, K. Hattori, S. Dias et al., "Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand, " Cell, vol. 109, no. 5, pp. 625-637, 2002.
78. S. Huang, M. Van Arsdall, S. Tedjarati et al., "Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice, " Journal of the National Cancer Institute, vol. 94, no. 15, pp. 1134-1142, 2002.
79. F. Shojaei, M. Singh, J. D. Thompson, and N. Ferrara, "Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 7, pp. 2640-2645, 2008.
80. F. Shojaei, X. Wu, C. Zhong et al., "Bv8 regulates myeloid-celldependent tumour angiogenesis, " Nature, vol. 450, no. 7171, pp. 825-831, 2007.
81. G. P. Gupta and J. Massagu, "Cancer metastasis: building a framework, " Cell, vol. 127, no. 4, pp. 679-695, 2006.
82. C.-F. Wu, W.-C. Chiang, C.-F. Lai et al., "Transforming growth factor-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis, " American Journal of Pathology, vol. 182, no. 1, pp. 118-131, 2013.
83. J. E. De Larco, B. R. K. Wuertz, and L. T. Furcht, "The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8, " Clinical Cancer Research, vol. 10, no. 15, pp. 4895-4900, 2004.
84. J.D. Spicer, B. McDonald, J. J. Cools-Lartigue et al., "Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells, " Cancer Research, vol. 72, no. 16, pp. 3919-3927, 2012.
85. Z. G. Fridlender and S. M. Albelda, "Tumor-Associated neutrophils: friend or foe?" Carcinogenesis, vol. 33, no. 5, pp. 949-955, 2012.
86. A. M. Houghton, D. M. Rzymkiewicz, H. Ji et al., "Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth, " Nature Medicine, vol. 16, no. 2, pp. 219-223, 2010.
87. P. Auguste, S. Lemiere, F. Larrieu-Lahargue, and A. Bikfalvi, "Molecular mechanisms of tumor vascularization, " Critical Reviews in Oncology/Hematology, vol. 54, no. 1, pp. 53-61, 2005.
88. M. J. Slattery and C. Dong, "Neutrophils influence melanoma adhesion and migration under flow conditions, " International Journal of Cancer, vol. 106, no. 5, pp. 713-722, 2003.
89. S. J. Huh, S. Liang, A. Sharma, C. Dong, and G. P. Robertson, "Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development, " Cancer Research, vol. 70, no. 14, pp. 6071-6082, 2010.
90. J. Cools-Lartigue, J. Spicer, B. McDonald et al., "Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis, " Journal of Clinical Investigation, vol. 123, no. 8, pp. 3446-3458, 2013.
91. J. A. Joyce and J.W. Pollard, "Microenvironmental regulation of metastasis, " Nature Reviews Cancer, vol. 9, no. 4, pp. 239-252, 2009.
92. J. T. Erler, K. L. Bennewith, T. R. Cox et al., "Hypoxiainduced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche, " Cancer Cell, vol. 15, no. 1, pp. 35-44, 2009.
93. R. N. Kaplan, R. D. Riba, S. Zacharoulis et al., "VEGFR1-positive haematopoietic bone marrow progenitors initiate the premetastatic niche, " Nature, vol. 438, no. 7069, pp. 820-827, 2005.
94. R. N. Kaplan, S. Rafii, and D. Lyden, "Preparing the soil: The premetastatic niche, " Cancer Research, vol. 66, no. 23, pp. 11089-11093, 2006.
95. J. P. Sleeman, "The metastatic niche and stromal progression, " Cancer and Metastasis Reviews, vol. 31, no. 3-4, pp. 429-440, 2012.
96. J. Sceneay, M. J. Smyth, and A.Mller, "The pre-metastatic niche: finding common ground, " Cancer and Metastasis Reviews, vol. 32, no. 3-4, pp. 449-464, 2013.
97. S. Hiratsuka, A. Watanabe, H. Aburatani, and Y. Maru, "Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis, " Nature Cell Biology, vol. 8, no. 12, pp. 1369-1375, 2006.
98. S. Hiratsuka, A. Watanabe, Y. Sakurai et al., "The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a premetastatic phase, " Nature Cell Biology, vol. 10, no. 11, pp. 1349-1355, 2008.
99. H. H. Yan, M. Pickup, Y. Pang et al., "Gr-1+CD11b+myeloid cells tip the balance ofimmune protection to tumor promotion in the premetastatic lung, " Cancer Research, vol. 70, no. 15, pp. 6139-6149, 2010.
100. H. B. Acuff, K. J. Carter, B. Fingleton, D. L. Gorden, and L. M. Matrisian, "Matrixmetalloproteinase-9 frombone marrowderived cells contributes to survival but not growth of tumor cells in the lung microenvironment, " Cancer Research, vol. 66, no. 1, pp. 259-266, 2006.
101. M. Radsak, C. Iking-Konert, S. Stegmaier, K. Andrassy, and G. M. Hnsch, "Polymorphonuclear neutrophils as accessory cells for T-cell activation: major histocompatibility complex class II restricted antigen-dependent induction of T-cell proliferation, " Immunology, vol. 101, no. 4, pp. 521-530, 2000.
102. N. S. Potter and C. V. Harding, "Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes, " Journal of Immunology, vol. 167, no. 5, pp. 2538-2546, 2001.
103. E. Reali, R. Guerrini, S. Moretti et al., "Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxicT lymphocytes, " Journal of Leukocyte Biology, vol. 60, no. 2, pp. 207-213, 1996.
104. J. Pillay, V. M. Kamp, E. Van Hoffen et al., "A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1, " Journal of Clinical Investigation, vol. 122, no. 1, pp. 327-336, 2012.
105. M. Munder, F. Mollinedo, J. Calafat et al., "Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity, " Blood, vol. 105, no. 6, pp. 2549-2556, 2005.
106. J.-I. Youn, S. Nagaraj, M. Collazo, and D. I. Gabrilovich, "Subsets of myeloid-derived suppressor cells in tumor-bearing mice, " Journal of Immunology, vol. 181, no. 8, pp. 5791-5802, 2008.
107. L. C. Jacobsen, K. Theilgaard-Mnch, E. I. Christensen, and N. Borregaard, "Arginase 1 is expressed in myelocytes/metamyelocytes and localized in gelatinase granules of human neutrophils, " Blood, vol. 109, no. 7, pp. 3084-3087, 2007.
108. P. C. Rodriguez, M. S. Ernstoff, C. Hernandez et al., "Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes, " Cancer Research, vol. 69, no. 4, pp. 1553-1560, 2009.
109. A. H. Zea, P. C. Rodriguez, M. B. Atkins et al., "Arginaseproducing myeloid suppressor cells in renal cell carcinoma patients: A mechanism of tumor evasion, " Cancer Research, vol. 65, no. 8, pp. 3044-3048, 2005.
110. S. B. Coffelt, K. Kersten, C. W. Doornebal et al., "IL-17-producing T cells and neutrophils conspire to promote breast cancer metastasis, " Nature, vol. 522, no. 7556, pp. 345-348, 2015.
111. H. K. Jensen, F. Donskov, N. Marcussen, M. Nordsmark, F. Lundbeck, and H. von der Maase, "Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma, " Journal of Clinical Oncology, vol. 27, no. 28, pp. 4709-4717, 2009.
112. K. Xie, "Interleukin-8 and human cancer biology, " Cytokine and Growth Factor Reviews, vol. 12, no. 4, pp. 375-391, 2001.
113. A. Bellocq, M. Antoine, A. Flahault et al., "Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome, " American Journal of Pathology, vol. 152, no. 1, pp. 83-92, 1998.
114. L.-F. Lee, R. P. Hellendall, Y. Wang et al., "IL-8 reduced tumorigenicity of human ovarian cancer in vivo due to neutrophil infiltration, " Journal of Immunology, vol. 164, no. 5, pp. 2769-2775, 2000.
115. H. Schaider, M. Oka, T. Bogenrieder et al., "Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8, " International Journal of Cancer, vol. 103, no. 3, pp. 335-343, 2003.
116. G. Opdenakker and J. Van Damme, "The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines, " International Journal of Developmental Biology, vol. 48, no. 5-6, pp. 519-527, 2004.
117. M. P. Keane, J. A. Belperio, Y. Y. Xue, M. D. Burdick, and R. M. Strieter, "Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer, " Journal of Immunology, vol. 172, no. 5, pp. 2853-2860, 2004.
118. H. Katoh, D. Wang, T. Daikoku, H. Sun, S. K. Dey, and R. N. DuBois, "CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-Associated tumorigenesis, " Cancer Cell, vol. 24, no. 5, pp. 631-644, 2013.
119. J. Arnold, E. C. De Boer, M. A. ODonnell, A. Bhle, and S. Brandau, "Immunotherapy of experimental bladder cancer with recombinant BCGexpressing interferon, " Journal of Immunotherapy, vol. 27, no. 2, pp. 116-123, 2004.
120. O. Florey and D. O. Haskard, "Sphingosine 1-phosphate enhances Fc receptor-mediated neutrophil activation and recruitment under flow conditions, "The Journal of Immunology, vol. 183, no. 4, pp. 2330-2336, 2009.
121. R. H. Wenger, "Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression, " The FASEB Journal, vol. 16, no. 10, pp. 1151-1162, 2002.
122. G. Christoffersson, E. Vagesj, J. Vandooren et al., "VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue, " Blood, vol. 120, no. 23, pp. 4653-4662, 2012.
123. M. Grunewald, I. Avraham, Y. Dor et al., "VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells, " Cell, vol. 124, no. 1, pp. 175-189, 2006.
124. J.M. Devery, N. J.C. King, and C.L. Geczy, "Acute inflammatory activity of the S100 protein CP-10. Activation of neutrophils in vivo and in vitro, " Journal of Immunology, vol. 152, no. 4, pp. 1888-1897, 1994.
125. B. Amulic, C. Cazalet, G. L. Hayes, K. D. Metzler, and A. Zychlinsky, "Neutrophil function: from mechanisms to disease, " Annual Review of Immunology, vol. 30, pp. 459-489, 2012.
126. M. L. Gabelloni, A. S. Trevani, J. Sabatt, and J. Geffner, "Mechanisms regulating neutrophil survival and cell death, " Seminars in Immunopathology, vol. 35, no. 4, pp. 423-437, 2013.
127. W. C. Liles, P. A. Kiener, J. A. Ledbetter, A. Aruffo, and S. J. Klebanoff, "Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils, " Journal of ExperimentalMedicine, vol. 184, no. 2, pp. 429-440, 1996.
128. M. Chawla-Sarkar, D. W. Leaman, and E. C. Borden, "Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-Alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines, " Clinical Cancer Research, vol. 7, no. 6, pp. 1821-1831, 2001.
129. C. Selleri, T. Sato, L. Del Vecchio et al., "Involvement of fasmediated apoptosis in the inhibitory effects of interferon-in chronic myelogenous leukemia, " Blood, vol. 89, no. 3, pp. 957-964, 1997.
130. T. Kuijpers and R. Lutter, "Inflammation and repeated infections in CGD: Two sides of a coin, " Cellular and Molecular Life Sciences, vol. 69, no. 1, pp. 7-15, 2012.
131. Y. Kasahara, K. Iwai, A. Yachie et al., "Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils, " Blood, vol. 89, no. 5, pp. 1748-1753, 1997.
132. H. Lundqvist-Gustafsson and T. Bengtsson, "Activation of the granule pool of the NADPH oxidase accelerates apoptosis in human neutrophils, " Journal of Leukocyte Biology, vol. 65, no. 2, pp. 196-204, 1999.
133. B. Dibbert, M. Weber, W. H. Nikolaizik et al., "Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: A general mechanism to accumulate effector cells in inflammation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 23, pp. 13330-13335, 1999.
134. N. A. Maianski, D. Roos, and T. W. Kuijpers, "Bid truncation, Bid/Bax targeting to the mitochondria, and caspase activation associated with neutrophil apoptosis are inhibited by granulocyte colony-stimulating factor, " Journal of Immunology, vol. 172, no. 11, pp. 7024-7030, 2004.